Clinical trial
Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome
NCT02196376 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome
- Lead sponsor
- Vanderbilt University
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 31, 2014
- Completion date
- July 31, 2029
- Enrollment
- 212 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.